North America Veterinary Point of Care Blood Gas Analyzer Market Analysis (2017-2023)
Special Offering : Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The North America Veterinary Point of Care Blood Gas Analyzers Market would witness market growth of 4.1% CAGR during the forecast period (2017-2023). Veterinary blood gas analyzer are used in measuring pH levels, blood gases, electrolytes, and metabolites parameters in the blood specimen. These devices offer convenient testing options and also facilitate rapid diagnosis. Acid-base and respiratory issues are some of the common issues among hospitalized animals. Therefore, the blood gas analyzers have grown popular as diagnosing and monitoring tools. Growing inclination towards owning companion animals, technological advancements in the blood gas analyzers, growing awareness about animal health, increasing expenditures on animal welfare are the factors that drive the growth of the veterinary point of care blood gas analyzers market. Additionally, growing number of veterinary clinics and availability of affordable blood gas analyzers to private veterinary clinics further ads to the market growth.
Based on modality, the market is segmented into PorTABLE Analyzers and Handheld Analyzers. Based on animal, the market is segmented into Companion Animals, Poultry & Dairy animals, Livestock Animals, and Others. Based on End user, the market is segmented into Veterinary Clinics, Veterinary Laboratories, Research Laboratories, and Others. The report also covers country wise segmentation of Veterinary Point of Care Blood Gas Analyzers market. The countries included in the report are US, Mexico, Canada, and Rest of North America. The market research report covers the analysis of key stake holders of the North America Veterinary Point of Care Blood Gas Analyzers Market.
Key companies profiled in the report include Heska Corporation, Vepalabs, Nova Biomedical, LifeHealth, LLC, Abaxis, Inc., F. Hoffmann-La Roche AG, Bayer AG, Siemens Healthcare, OPTI Medical Systems Inc., and Radiometer Medical ApS.